Revance Therapeutics (NASDAQ:RVNC) PT Lowered to $12.00 at HC Wainwright
Revance Therapeutics (NASDAQ:RVNC – Free Report) had its price objective lowered by HC Wainwright from $15.00 to $12.00 in a research report released on Friday, Benzinga reports. HC Wainwright currently has a buy rating on the biopharmaceutical company’s stock. Several other equities research analysts have also issued reports on RVNC. The Goldman Sachs Group lowered […]
More Stories
PaLM AI (PALM) Price Tops $0.37 on Top Exchanges
PaLM AI (PALM) traded up 1.7% against the dollar during the 24-hour period ending at 20:00 PM ET on September...
Defira 24 Hour Volume Reaches $0.19 (FIRA)
Defira (FIRA) traded up 0.6% against the dollar during the 1 day period ending at 20:00 PM Eastern on September...
Ethereum Classic Price Reaches $17.60 on Major Exchanges (ETC)
Ethereum Classic (ETC) traded 1.4% higher against the US dollar during the 24 hour period ending at 20:00 PM E.T....
Stonebrook Private Inc. Purchases 153 Shares of AbbVie Inc. (NYSE:ABBV)
Stonebrook Private Inc. raised its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 5.5% in the second...
Frax Price Index Share Price Down 15.8% Over Last 7 Days (FPIS)
Frax Price Index Share (FPIS) traded 0.2% higher against the US dollar during the 24 hour period ending at 20:00...
Cookie (COOKIE) Hits 24 Hour Volume of $510,947.22
Cookie (COOKIE) traded 5.1% higher against the dollar during the 24-hour period ending at 20:00 PM E.T. on September 7th....